Press releases
- Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
- Agenus Announces Reverse Stock Split of Common Stock
- Agenus Reports Fourth Quarter and Full Year 2023 Results
- Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
- Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
- Agenus to Participate in Leerink Partners Global Biopharma Conference
More ▼
Key statistics
As of last trade Agenus Inc (AJ81:STU) traded at 7.95, 7.40% above its 52-week low of 7.40, set on Apr 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.16 |
---|---|
High | 8.16 |
Low | 7.73 |
Bid | 0.3988 |
Offer | 0.4321 |
Previous close | 7.95 |
Average volume | -- |
---|---|
Shares outstanding | 20.28m |
Free float | 20.03m |
P/E (TTM) | -- |
Market cap | 243.62m USD |
EPS (TTM) | -13.95 USD |
Data delayed at least 15 minutes, as of Apr 11 2024.
More ▼